Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer | Synapse

June 12, 2014Open Access

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer

MOMayumi OzawaYokohama City University Medical Center YIYasushi IchikawaHimeji Medical Center YZYun‐Wen ZhengJiangsu University

Key Points

Key points are not available for this paper at this time.

Abstract

CD44 is an important CSC marker in CRC patients. Furthermore, CRC patients with high expression of CD44v2 have a poorer prognosis than patients with other CD44 variants.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Ozawa et al. (Thu,) studied this question.

synapsesocial.com/papers/69d901c3a6384138a5d17db1 https://doi.org/https://doi.org/10.1038/bjc.2014.253

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer2012 · 81 citations
2Stem cells, cancer, and cancer stem cells2001 · 9,731 citations
3ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays2009 · 2,199 citations
4Identification and expansion of human colon-cancer-initiating cells2006 · 3,993 citations
5TNM Classification of Malignant Tumours2003 · 3,963 citations